Novel prime-boost vaccine strategies against HIV-1

Novel prime-boost vaccine strategies against HIV-1

Introduction: Given the complexities of HIV infection and the HIV genetic heterogeneity, a successful HIV vaccine should elicit broad adaptive and innate immune responses. Vaccine prime-boost platforms may achieve this goal. Several factors including selection of antigen, type of vector, delivery ro...

Bibliografski detalji
Glavni autori:	Jean-Louis Excler, Jerome H. Kim
Format:	Članak
Jezik:	English
Izdano:	Taylor & Francis Group 2019-08-01
Serija:	Expert Review of Vaccines
Teme:	hiv vaccine prime-boost viral vector alvac ad26 mosaic envelope protein efficacy immune correlates of risk
Online pristup:	http://dx.doi.org/10.1080/14760584.2019.1640117

Slični predmeti

Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines
od: Shixia Wang, i dr.
Izdano: (2017-12-01)

A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks
od: Georgi Shukarev, i dr.
Izdano: (2017-02-01)

Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection
od: Muriel Metko, i dr.
Izdano: (2024-10-01)

Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
od: Xi Yang, i dr.
Izdano: (2019-01-01)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
od: Jaejo Kim, i dr.
Izdano: (2023-02-01)

Modeling the Dependence of Immunodominance on T Cell Dynamics in Prime-Boost Vaccines
od: Clemente Fernandez Arias, i dr.
Izdano: (2020-12-01)

A Zigzag but Upward Way to Develop an HIV-1 Vaccine
od: Ziyu Wen, i dr.
Izdano: (2020-09-01)

An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine
od: Hana M El Sahly, i dr.
Izdano: (2020-12-01)

Abstract Priming and the Lexical Boost Effect across Development in a Structurally Biased Language
od: Alina Kholodova, i dr.
Izdano: (2023-11-01)

DNA Prime and Recombinant Protein Boost Vaccination Confers Chickens with Enhanced Protection against Chicken Infectious Anemia Virus
od: Ling Liu, i dr.
Izdano: (2022-09-01)

Revival of the heterologous prime‐boost technique in COVID‐19: An outlook from the history of outbreaks
od: Amna Siddiqui, i dr.
Izdano: (2022-03-01)

Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
od: Elena Pettini, i dr.
Izdano: (2021-03-01)

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
od: Ros Chapman, i dr.
Izdano: (2021-11-01)

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
od: Noopur Bhatnagar, i dr.
Izdano: (2023-07-01)

Passive and active antibody studies in primates to inform HIV vaccines
od: Ann J. Hessell, i dr.
Izdano: (2018-02-01)

Exploring Prime-Boost Vaccination Regimens with Different H1N1 Swine Influenza A Virus Strains and Vaccine Platforms
od: Anna Parys, i dr.
Izdano: (2022-10-01)

Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses
od: Antonia Radaelli, i dr.
Izdano: (2024-11-01)

Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model
od: Sharon Chepkwony, i dr.
Izdano: (2020-09-01)

Antibody Response after Homologous and Heterologous Prime–Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort
od: Nihad Adnan, i dr.
Izdano: (2024-04-01)

Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
od: Anna Timofeeva, i dr.
Izdano: (2022-03-01)

Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model
od: Vasilis C. Pliasas, i dr.
Izdano: (2023-10-01)

Modified Boosted - p24 Antigen can Predict HIV-1 RNA Viral Load (Ampiclor HIV-1 Monitor)
od: Nirun Vanprapar, i dr.
Izdano: (2005-06-01)

Immunoinformatic design of a multivalent vaccine against Brucella abortus and its evaluation in a murine model using a DNA prime-protein boost strategy
od: Raúl E. Molina, i dr.
Izdano: (2024-11-01)

HIV-1 Entry and Membrane Fusion Inhibitors
od: Tianshu Xiao, i dr.
Izdano: (2021-04-01)

Heterologous Systemic Prime–Intranasal Boosting Using a Spore SARS-CoV-2 Vaccine Confers Mucosal Immunity and Cross-Reactive Antibodies in Mice as well as Protection in Hamsters
od: Paidamoyo M. Katsande, i dr.
Izdano: (2022-11-01)

Heterologous Prime-Boost Immunization with DNA Vaccine and Modified Recombinant Proteins Enhances Immune Response against <i>Trueperella pyogenes</i> in Mice
od: Ting Huang, i dr.
Izdano: (2022-05-01)

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine
od: Surakameth Mahasirimongkol, i dr.
Izdano: (2022-03-01)

Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice
od: Monalisa Martins Trentini, i dr.
Izdano: (2024-01-01)

The Results of Clinical Trials of Recombinant Vaccine Virus, MVA Strain, Expressing Genes of Human Immunodeficiency Virus
od: L. F. Stovba, i dr.
Izdano: (2021-10-01)

Safety and Efficacy of the Common Vaccines against COVID-19
od: Ying Liu, i dr.
Izdano: (2022-03-01)

Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models
od: Lynette Siv Chea, i dr.
Izdano: (2017-10-01)

boostingDEA: A boosting approach to Data Envelopment Analysis in R
od: Maria D. Guillen, i dr.
Izdano: (2023-12-01)

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
od: Guy Cohen, i dr.
Izdano: (2022-11-01)

Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review
od: Ishan Garg, i dr.
Izdano: (2022-07-01)

Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
od: Alemu Tekewe Mogus, i dr.
Izdano: (2020-12-01)

Delivering CRISPR to the HIV-1 reservoirs
od: Theodore E. Gurrola, i dr.
Izdano: (2024-05-01)

HIV Env conserved element DNA vaccine alters immunodominance in macaques
od: Xintao Hu, i dr.
Izdano: (2017-12-01)

T cell-based strategies for HIV-1 vaccines
od: Bette Korber, i dr.
Izdano: (2020-03-01)

Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques
od: Benjamin N. Bimber, i dr.
Izdano: (2024-08-01)

Near Prime Spectrum
od: Hadi J Mustafa, i dr.
Izdano: (2013-12-01)